ArticleInflammatory bowel diseases2025

One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn's Disease: The K-STAR Study.

Chang Kyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.